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Should stroke physicians assess cognition and mood?  
It would seem intuitive that for a ‘brain’ disease such as stroke, the examination of memory, thinking 
and mood would be fundamental to the clinical assessment.  Yet in contemporary stroke practice we 
have tended to focus on the physical manifestations of stroke and neuropsychological aspects have 
received little, if any, attention. 1 Thankfully the landscape is changing, there is an increasing 
recognition of the importance of the psychological consequences of stroke and a growing evidence 
base and standardisation around assessment.2,3,4  The stroke physician cannot be expected to take 
on the role of the neuropsychology specialist and there will always be cases where expert input is 
required.  However, a basic appreciation of how to approach cognitive and mood assessment should 
now be mandatory for all working in stroke care.  
In this review we discuss assessment of cognitive function and mood.  We have drawn on evidence 
from recent research, particularly systematic review.3  We do not offer a comprehensive critique of 
all cognitive and mood assessment tools.  Rather, we suggest a framework for assessment that 
emphasises the need for differing approaches to testing at differing points in the stroke 
pathway.(Figure 1)   
 
The importance of cognition and mood in stroke 
The arguments in favour of assessing cognition and mood in stroke are underscored by two 
fundamental facts.  Cognitive and mood problems are common following stroke and are both 
associated with poor outcomes.  One in three people will experience stroke, dementia or both.5  The 
definitive systematic review describing cognitive problems following stroke, reports incident 
dementia rates of around 10%, rising to 30% with recurrent events.6  Immediately following stroke, 
cognitive impairments are seen in around 70% of patients.7  The patient with cognitive problems has 
increased risk of poor functional outcome, increased length of stay and increased mortality.5  In 
recent research and policy the focus has shifted from those with frank dementia syndromes, to the 
much larger population of stroke survivors with cognitive impairments that are not sufficient to 
meet diagnostic criteria but still impact on quality of life.  Here there is greater potential for 
prevention, modification or adaptation.   
The data are similar for post stroke depression.  At any point in time around one third of stroke 
survivors have depression and this is associated with increased disability and mortality.8  Perhaps the 
most compelling argument for the importance of the psychological aspects of stroke comes from 
stroke survivors themselves.  In a recent priority setting exercise, stroke survivors voted that 
cognitive aspects of stroke are their key priority.9  This finding is echoed by results from patient and 
carer workshops organised by the Stroke Association, UK and other third sector groups.10   
 
Screening for cognitive and mood issues following stroke 
There are two broad approaches to neuropsychological assessment in stroke, targeted assessment 
of patients where there is concern about a cognitive or mood problem and unselected screening of 
all stroke patients.  The two are not mutually exclusive and the patient who ‘passes’ a screening test 
but complains of cognitive or mood issues should not be denied a more detailed assessment.  
The rationale for screening all stroke patients is plausible and guidelines from specialist societies 
recommend early screening.(Figure 2)  Psychological problems are common and early identification 
should allow treatment initiation, rehabilitation that is personalised to the individual and 
appropriate goal setting.  However, we have no empirical evidence of clinical or cost benefit of this 
approach.  Those who argue against early cognitive screening, cite the limited understanding of the 
natural history of the condition, the lack of any proven treatment, and the potential harms of 
mislabelling a patient as having a neuropsychological syndrome.  If we consider the Wilson-Junger 
criteria11 for assessing a screening programme, in the context of stroke cognitive screening we see 
that there are several areas where knowledge is lacking and research in this field is urgently 
required.(Table 1)  
 
Assessing pre-stroke problems 
Although the theme of this review is post stroke assessment, to put these tests into context it is 
necessary to understand the pre-stroke state.  Stroke is a disease of older adults and older adults 
often have cognitive and mood problems.  Systematic reviews suggest that at least 10% of stroke 
admissions have a dementia diagnosis pre-stroke5, with similar prevalence for pre-stroke 
depression.12  These figures are likely to be an underestimate, often cognitive and mood problems 
are only detected by healthcare professionals when the person is assessed for another medical 
conditions such as stroke.   
Various tools exist to retrospectively assess for cognitive impairments and if used in the immediate 
period following stroke can give a picture of the pre-stroke state.  The usual format is a short 
questionnaire completed by a collateral information source, for example a spouse or relative.  
Examples include the Informant Questionnaire for Cognitive Decline in the Elderly (IQCODE)13; the 
Ascertain Dementia Eight-Item screen (AD-8)14 and the informant component of the General 
Practitioner assessment of Cognition (GP-Cog)15.  These tools have features that make them suitable 
for assessment immediately after stroke.  They are short, standardised and offer a method of 
describing function when the patient may be too unwell for direct assessment.  Informant tools have 
reasonable test accuracy for detection of dementia in community and memory clinic settings16 and 
by using the informant’s perception of cognitive and functional change these tools are less prone to 
cultural biases seen with other tests.  However, to date there has been no validated assessment of 
their performance for the detection of pre-stroke dementia.17  IQCODE at time of stroke may also 
have prognostic utility; a higher IQCODE score is a specific but insensitive tool for predicting future 
dementia.17  There are limitations to informant questionnaires.  The availability of an informant who 
is willing or able to comment on the patient’s pre-stroke state is not guaranteed.  If the tool is not 
used early after the stroke event then informants may struggle to give an account of pre-stroke 
cognition and often describe the cognitive problems that they see following the stroke. 
The clinician may wish to assess other aspects of the pre-stroke condition.  As part of a more formal 
neuropsychological assessment, a measure of premorbid intelligence is often useful.  The National 
Adult Reading Test (NART) is used in this regard, as vocabulary is said to be better preserved in 
neurodegenerative conditions than other cognitive abilities.18  However, the correlation between 
NART and early life intelligence is not perfect18 and whether NART is useful in acute stroke, 
particularly dominant hemisphere stroke, is less clear.   
Informant based depression screens have been described and could be used in a similar way to 
assess pre-stroke mood.  However, as with cognitive assessments these tools have not been 
validated for use in acute stroke.19  Screening medical records for a previous diagnosis of mood 
disorder can be equally useful with a low opportunity cost.  Assessment of cognition and mood 
should always be accompanied by an assessment of function.  Traditionally the assessment of pre-
stroke function has used the modified Rankin Scale (mRS).20  Newer assessments designed to 
describe physical and cognitive frailty may also provide useful information.  
 
 
Assessment in the hyper-acute stroke unit  
Cognitive and mood assessment may not seem an immediate priority in the early period following 
stroke.  A comprehensive multi-domain assessment is unlikely to be feasible, but brief assessments 
are possible and potentially useful in the hyper-acute setting.  Even in very time limited settings, 
assessments for pre-stroke cognition, delirium and brief cognitive testing are possible and may be 
useful in guiding subsequent management.(Figure 1) 
Examples of bedside cognitive tests of less than five minutes duration include Hodkinson’s ten-point 
Abbreviated Mental Test (AMT)21; the Mini-Cog22 and abbreviated forms of the Montreal Cognitive 
Assessment (MoCA).23  All have proven validity in assessment of older adults, but the evidence base 
for their use in stroke is limited.24  Short screens for mood disorder are also available, for example 
the two-question based Patient Health Questionnaire (PHQ-2).25  These tests are clearly not 
diagnostic, but can be used as a triage tool in the acute period.  If a patient struggles with the brief 
assessments then the need for further assessment to determine the nature of the impairment can 
be highlighted to the team.  Certainly, short tests are more sensitive to cognitive problems than 
unstructured clinical assessment.26   
Perhaps more pertinent to the hyper-acute setting is screening for delirium.  The syndrome of 
delirium is a common complication of acute illness.  Delirium is less well studied in stroke than in 
other conditions, but where data are available these suggest that delirium is seen in one in four 
stroke patients during the acute period.27  The finding of delirium has implications for both the short 
and longer term.27  Incident delirium can signal the emergence of a stroke related complication such 
as pneumonia and in the longer term the presence of delirium is associated with poor outcomes.  
Screening tools for delirium are available and many have good accuracy when compared to gold 
standard clinical assessment.  The 4-A test is a short screening tool for delirium that is available in 
several languages, is quick to administer with little training and has some supportive data in stroke.26  
The Confusion Assessment Method (CAM) also has proven accuracy for diagnosis of delirium in 
stroke.28  For patients with aphasia or other communication problems, the CAM modified for use in 
Intensive Care Settings (CAM-ICU) can be used as it does not require any verbal response for 
completion.29  
It is routine to assess stroke related neurological impairments on admission using a standardised 
tool such as the National Institutes of Health Stroke Scale (NIHSS).  The information from this 
assessment can also be useful for subsequent cognitive and mood testing.  NIHSS will detect those 
with severe communication or visuospatial problems who may require an adapted approach to 
assessment.  Physical impairments detected by NIHSS may also be relevant to the cognitive 
assessment, for example the person with severe weakness in the dominant hand may struggle with 
pencil and paper based assessments.  Although not part of the traditional stroke examination, a 
screening assessment to detect major hearing or visual impairments will also inform any future 
testing.  
 
Assessment in the stroke unit  
The opportunity for slightly more detailed cognitive and mood assessment can come once the 
patient has stabilised medically.  A full neuropsychological battery or diagnostic interview may still 
not be appropriate or feasible at this point, however a multi-domain screening tool can be a useful 
part of the clinical assessment.     
The number of cognitive screening tests available to the clinician is large and continues to grow.  
Historically there has been little consistency in the cognitive or mood test employed in stroke30  and 
choice of assessment often elicits strong opinion that is not always grounded in evidence.  Stroke 
specific data on the properties of psychological assessment tools has recently become available and 
we no longer have to extrapolate from studies performed in community or memory clinic settings.   
There is no perfect psychological assessment and the preferred tool will vary with the intended 
purpose of testing, the case-mix of the population and the skills of the person administering the test.  
We suggest some criteria for a psychological screening tool to be used in the stroke unit.(Figure 3)  
The key features are:feasibility for use in acute stroke setting; acceptable test properties and 
coverage of core cognitive domains (DSM-5 suggests including tests of complex attention; executive 
function; learning & memory; language; perceptual-motor; social cognition).  Most screening tests 
cover these domains to a greater or lesser extent and if the clinician is particularly interested in 
assessing a certain domain then this can guide the preferred test strategy.(Table 2).  Assessment of 
cognition and mood must be interpreted in the context of language and culture.  Local adaptation 
with robust validation is required for international use of assessment tools, indeed this was the core 
rationale for the National Institute of Neurological disorders and stroke–Canadian Stroke network 
(NINDS-CSN) Harmonization effort.4 
Test accuracy is an important consideration i.e. does the test correctly select people with the 
condition of interest as diagnosed by a gold standard.31  In the context of acute stroke it is debatable 
which gold standard is the appropriate comparator.  Diagnostic testing for dementia is not 
recommended immediately after stroke and so comparison with a clinical diagnosis may not be 
suitable.  Arguably a more meaningful analysis would compare a short screening test with a more 
detailed assessment.  Alternatively one could look at how well a screening tool assessment predicts 
subsequent cognitive problems (delayed verification).31  The ‘optimal’ test accuracy is also not 
straightforward.  There is an inverse relationship between the test properties of sensitivity and 
specificity and depending on the purpose of testing one may be preferred over the other.  For 
example, if the intention is to pick up all patients with possible psychological problems, at the cost of 
‘false positives’, then a higher sensitivity may be preferred. 
Recent reviews have used novel meta-analytical techniques to collate and compare the test accuracy 
of cognitive and mood assessments in the stroke setting.19,24  For cognitive assessment in stroke, 
despite the large number of tests potentially available, only two tests had sufficient numbers of 
papers to allow meta-analysis: Folstein’s Mini-Mental State Examination (MMSE) and MoCA.24  The 
pooled data show that at usual test threshold, MoCA is extremely sensitive but has poor specificity.  
Using an adjusted threshold (MoCA<22) the sensitivity and specificity are less extreme.(Table 2)  
Defining the optimal threshold for a stroke assessment scale is an area that requires more research, 
ideally this work should be based on data from the population in which the test will be employed.    
Since the publication of this review, new screening tools developed specifically for stroke have been 
described such as the Oxford Cognitive Screen (OCS).32  Initial data suggest that OCS may have some 
advantages over other cognitive screens. In particular it is designed to offer domain specific results 
rather than a reductionist pass/fail; it allows finger pointing response to minimize bias from aphasia 
and incorporates assessment of apraxia and neglect. 
For depression assessments, five tests had sufficient data to allow meta-analysis (Beck Depression 
Index; PHQ-2; PHQ-9; Hospital Anxiety and Depression Score [HADS] and Hamilton Rating Scale for 
Depression).19  Accuracy was broadly similar across the tests and all were best suited to ‘rule-out’ 
depression.  The majority of these tests assess for symptoms of depression rather than diagnose the 
clinical syndrome of depression.  When using these tools there may be overlap of potential 
depression symptoms with non-psychological stroke effects, for example weight loss is often seen 
following acute illness such as stroke.  A depression screen with less weighting for somatic 
symptoms would seem reasonable in acute stroke settings.    
Post stroke neuropsychological recovery is a dynamic process and this must be borne in mind when 
interpreting cognitive and mood screening tools.  In studies describing assessment in the first days 
post stroke, the majority of patients screen ‘positive’ for cognitive and mood disorders.33  This is 
perhaps not surprising in the context of a potentially life changing brain injury.  Over the next days 
and weeks many show improvement, highlighting the need for continued assessment over time.  
Post stroke checklists for use in outpatient services have been described that could be used in this 
regard.  Differing patients have differing cognitive and mood trajectory and the time-point of 
neuropsychological stability, if such a state exists, is not clear.   
 
Assessment in the rehabilitation unit or outpatient clinic 
Following the acute period, detailed assessment becomes more feasible and comprehensive 
neuropsychological assessment may have a role.  A neuropsychological battery (NPB) is considered a 
gold standard for detection of cognitive impairments, although is not sufficient alone to make a 
diagnosis of a dementia syndrome.  Neuropsychological batteries are substantially longer than 
screening tests with associated increased test burden for the patient.  The administration and 
interpretation of NPB data requires specialist training and ideally test results should be judged 
against population normative data.  For these reasons, assessment using a NPBs are reserved for 
selected patients (guidance suggests deferring this until at least three months post ictus).34  Even 
with case selection the aspiration of comprehensive neuropsychological assessment may be 
challenging to realise in a stroke setting.  Issues include, but are not limited to, training, availability 
of assessors, appropriate test materials and space for testing.   
NPBs comprise a series of individual tasks designed to assess each cognitive domain.  There is not a 
preferred battery for use in stroke and even within each domain, there is no agreed consensus on a 
preferred test.   Often the assessor will individualise the tests specific to the patient’s problems or 
the clinical question to be answered.  NINDS-CSN Harmonisation workshops have suggested a suite 
of NPBs for detection of vascular cognitive impairment4 with test protocols suitable for screening (5 
minutes); multi-domain testing (30 minutes) and comprehensive assessment (60 minutes).  The 
NINDS-CSN comprises validated domain specific tests, with population normed data and validated 
versions in several languages.4  
Although our focus is on formal psychological assessment, we should not under-estimate the utility 
of functional assessment in the stroke unit or rehabilitation facility.  Direct observation of a patient 
attempting a task such as meal preparation can give useful information on many aspects of cognition 
and this approach is often used by allied health professionals in their assessment.  A 
multidisciplinary assessment informed by neuropsychological testing, functional assessment and 
results of investigations such as neuroimaging are the ingredients required to make a diagnostic 
formulation and treatment plan.  
 
Assessment in clinical trials  
Historically, endpoints for stroke trials have mirrored those seen in cardiology with a composite 
outcome comprising vascular events and mortality.  For primary and secondary prevention trials this 
outcome is suitable but is overly reductionist for studies looking at stroke recovery.  In this instance, 
the guidance is to assess function and the most commonly reported measures are mRS, NIHSS and 
Barthel Index (BI).4  These assessments all focus on physical function and are poor measures of 
neuropsychological recovery.  Despite calls to include cognitive assessments in stroke trials, an 
assessment of cognition or mood is the exception rather than the rule and where psychological 
assessments are employed in trials there is little consistency in the choice of tool or the method of 
application.30   
The recent European Stroke Organisation/Karolinska Stroke Update offers guidance on the preferred 
measures for trials.35  The consensus statement recommends use of an informant measure such as 
IQCODE to assess pre-stroke cognitive impairment for participant selection or case mix adjustment.  
Two approaches to patient assessment are described, a short battery that can be administered by 
most researchers (MoCA, trail making tests and digit span) and an extended multi-domain test 
battery.  In addition they recommend consideration of other neuropsychological factors such as 
depression, fatigue, apathy and care-giver status.   
In clinical practice direct assessment is preferable, but in the context of a large multicentre trials or 
registries, remote centralised assessment may need to be considered for logistic and economic 
reasons.  Options include assessment via telephone, postal questionnaire, internet based 
questionnaires or remote video interview.  The most commonly used telephone cognitive 
assessment is the Telephone Interview for Cognitive Status (TICS).  TICS is based on MMSE although 
subsequent modification (TICS-m) offers a more comprehensive memory assessment.  TICS and TICS-
m have reasonable test accuracy for detection of Alzheimer’s dementia, but properties in stroke are 
less well studied.36  Modifications of the MoCA to make it suitable for telephone assessment have 
been described for use in stroke cohorts, with test accuracy similar to TICS-m.37  An obvious 
disadvantage of telephone assessment is that pencil and paper tests and assessment of visuospatial 
function are not possible.  In the future we will see increasing use of internet based self-assessment 
questionnaires.  Use of e-health resources is high and increasing among older adults in Europe 
making this a potentially feasible platform. However, validation in stroke cohorts will still be 
required before this approach could be recommended.   
The analysis of cognitive and mood data for trials presents further challenges.  A dichotomous 
outcome of impairment present or absent allows for ease of analysis but lacks granularity and may 
not have power to show between group differences.  Other approaches include creating hierarchical 
categories, assessment as a continuous scale and assessing against population normative data.  A 
composite of vascular events, physical recovery and cognition may have particular utility in trials of 
minor stroke or TIA.38  If a study is to include a range of stroke severities then inevitably not all 
assessments or items within an assessment will be completed.  For cognitive assessment this is a 
particular challenge and study protocols should have clear rules for how these missing data are 
handled in analyses.39   
 
Additional assessments 
For this review we have focussed on assessment of cognition and depression.  Within the rubric of 
psychological consequences of stroke are a number of other equally common and disabling 
conditions that should also be considered.  There is considerable overlap between many of these 
conditions and often in screening for one condition the assessor may notice issues suggestive of 
another neuropsychiatric problem.  Depression is not the only mood disorder associated with stroke 
and anxiety in various forms is increasingly recognised as a post stroke phenomenon.  Compared to 
depression, there are fewer anxiety screening tools and little validation of these tools in stroke 
cohorts.  For an initial brief screening assessment, the two-item Generalised Anxiety Disorder (GAD-
2) could be considered.  Other syndromes such as fatigue, emotionalism and apathy are also 
common although under-researched in the context of stroke.  There are assessment tools for all 
these conditions, but no consensus on the optimal assessment strategy.  The Neuropsychiatric 
Inventory Questionnaire for informants is often used in stroke cohorts and has been validated for 
this purpose.40  
 
Cognitive assessment to assign a diagnostic label  
An important purpose of assessment should be to make a diagnosis of dementia or depression.  
However, none of the tools discussed in this review are diagnostic in their own right.  The clinical 
label of dementia requires more than a demonstration of cognitive impairments.  This should not 
detract from the utility of cognitive screening.  Forming a dementia diagnosis is not the only 
rationale for assessing cognition.  Understanding a patient’s cognitive problems can help target the 
rehabilitation approach; can provide useful prognostic information and can highlight the emergence 
of complications such as delirium. 
Historical definitions of dementia that required impaired memory and evidence of progression over 
time were problematic in stroke where the patient could have disabling cognitive problems but 
preserved memory and/or where the cognitive deficits would not necessarily show a steady 
temporal decline.  The new terminologies of neurocognitive disorder (NCD) as outlined in Diagnostic 
and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) are better suited to stroke.   
Whichever classification is used, evidence of cognitive impairment is only part of the assessment 
there must also be an assessment of functional ability. In DSM-5 the ability to perform instrumental 
activities of daily living (ADL) distinguishes minor from major NCD, while loss of basic ADL defines 
severe NCD.  The importance of functional assessment should not be underestimated and recent 
reviews describe the tools available.4  In stroke we are very familiar with using scales mRS and BI and 
we should also incorporate these assessments into cognitive formulations.  
Going beyond ‘unspecified dementia’ to assign a more detailed pathological dementia diagnostic 
label comes with increased complexity.  DSM-5 recognises post stroke cognitive impairment as a 
distinct condition, but this is only one of a number of terms that have been used to describe 
dementia in the context of stroke disease.35  Recent attempts to provide a harmonised framework 
for the classification of vascular cognitive impairments are welcome and will hopefully be adopted 
by the clinical and research community.2,4  Most classifications define post-stroke dementias based 
on time from stroke, for example ‘..cognitive decline that begins after, but within six months of the 
stroke and does not recover’.2  The implications for assessment are that we should avoid assigning a 
diagnostic label until at least six months post ictus and longer periods of assessment may be 
preferable.     
 
Future Directions  
Neuropsychological assessment in stroke is moving from a niche, opinion based endeavour to an 
evidence based part of the standardised stroke assessment.  Considerable progress has been made 
in our understanding of cognitive and mood assessment in stroke but there is more work to be 
done.(Figure 4)  Future research should look at the utility of the very early assessment 
recommended in many guidelines.  Prospective cohorts with multi-domain assessment will allow a 
better understanding of the natural history of cognitive and mood problems.  Finally we should not 
forget the patient and carer’s voice and we need qualitative work to identify which 
neuropsychological aspects are of greatest importance and how the experience of cognitive and 
mood assessment can be optimised.  As we collect study level cognitive and mood data we should 
share this resource with other researchers and registries such as VISTA-Cog are important in this 
regard.    
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Table 1:Wilson-Jugner criteria applied to early cognitive assessment  
 
 
  
Criteria for neuropsychological screening     Applicable to (H)ASU  
Condition must be important     Yes 
Epidemiology & prognosis should be understood  Partly  
Test should be simple and safe      Partly  
Test should be validated for population    Partly 
Test should be acceptable to patients / testers   Unknown 
There should be an effective treatment    No 
There should be RCT evidence of screening efficacy  No 
The opportunity & economic cost should be described  No 
 
Table 2:Domain specific content and properties of commonly used cognitive screening tools (using 
DSM-5 domains) 
 
 ACE-R MMSE MoCA OCS TICS-m 
Duration 15-20 minutes ≤10 minutes 10 minutes 15-20 minutes 10 minutes  
Copyright 
status 
Freely available  Copyrighted, 
charge for use 
Freely available  Freely available  Freely available  
Complex 
Attention 
Serial subtraction 
Backwards spelling  
Serial subtraction Digit span 
Letter A tapping  
Serial subtraction 
Calculations 
 
Serial subtraction 
Count backwards 
Executive 
Function 
Verbal fluency 
 
 Trails  
Verbal Fluency  
Abstraction 
Trails  
Learning & 
Memory 
Orientation 
Three item recall 
Address recall 
Recognition  
Orientation 
Three item recall 
 
Orientation 
Five item recall 
 
 
Orientation 
Sentence recall 
Recognition   
 
Orientation 
Ten item recall 
Language  
 
Reading 
Comprehension 
Writing  
Repetition  
Naming 
Object naming 
Repetition 
Reading 
Writing  
Animal naming 
Repetition 
Object naming 
Semantics  
Sentence reading 
Semantics 
Repetition  
Perceptual-
motor  
Intersecting 
pentagons 
Clock draw 
Cube copy 
Counting dots 
Identify letters 
Intersecting 
pentagons 
Cube copy 
Clock draw 
Gesture imitation 
Cancellation test  
 
 
Social 
Cognition  
     
Sensitivity 
Specificity 
Cut off <88 
0.96 (0.90-1.00) 
0.70 (0.59-0.80) 
Cut off <27 
0.88 (0.82-0.92) 
0.62 (0.50-0.73)  
Cut off <26 
0.95 (0.89-0.98) 
0.45 (0.34-0.57)  
  
 
Table of commonly used multi-domain screening tools and domain specific content.  Domain items 
are labelled as per test authors. We recognise that test items often overlap, and an item may test 
more than one domain. Test accuracy data are against reference standard of neuropsychiatric 
battery or clinical assessment using data from meta-analyses where available.  
ACE-R:Addenbrookes Cognitive Examination Revised; MMSE:Mini Mental State Examination; 
OCS:Oxford Cognitive Screen; TICS-m:Telephone Interview for Cognitive Status Modified  
 
  
Figure 1:Neuropsychological assessment throughout the stroke pathway  
 
Schematic illustrating a potential approach to neuropsychological assessment at various stages in 
the stroke pathway.  The tests named are given as examples rather than recommendations.  Note 
how all elements are used to inform the clinical diagnosis.  Note also that the early assessments 
focus on pre-stroke cognition, delirium and stroke impairments rather than detailed cognitive 
assessment.   
IQCODE:Informant Questionnaire for Cognitive Decline in the Elderly; mRS:modified Rankin Scale; 
MoCA:Montreal Cognitive Assessment;  (mini-MoCA:short form of the MoCA; MoCA plus:MoCA with 
additional test as recommended by ESO); PHQ:Patient Health questionnaire; CAM-ICU:Confusion 
Assessment Method for the Intensive Care Unit; NIHSS:National Institutes Health Stroke Scale; 
NINDS-CSN:National Institute Neurological Disorders and Canadian Stroke Network; Centre for 
Epidemiologic Studies Depression; SCID:Structured Clinical Interview Depression; E-ADL:Extended 
Activities of Daily Living; HR-QoL:Health Related Quality of Life 
  
Figure 2:Guidelines on neuropsychological assessment in stroke 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3:MuSCoW chart detailing preferred properties of a neuropsychological screening tool 
 
 
 
  
Figure 4:Key messages for cognitive and mood assessment in stroke  
 
 
